Market Cap
₹98,732 Cr.
P/E
17.70
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Forensics

13 Yes

Positive for this company

2 Neutral

Neutral for this company

2 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE
Latest
19.36%
3yr Average
13.93%
5yr Average
13.73%
Net Profit Margin
Latest
18.27%
3yr Average
12.88%
5yr Average
12.57%
ROCE
Latest
26.75%
3yr Average
20.02%
5yr Average
17.57%
Debt to Equity
Latest
0.06
3yr Average
0.14
5yr Average
0.16
Market Share
2.04% (as of Jul 22)
Anti - Diabetes - Market Share
1.39% (as of Jul 22)
Anti-Infectives - Market Share
6.51% (as of Nov 21)
Antineo Plastic - Market Share
2.62% (as of Nov 21)
Blood Related - Market Share
2.39% (as of Jul 22)
Cardiovascular - Market Share
5.05% (as of Nov 21)
Dermatology - Market Share
0.01% (as of Oct 21)
Endocrinology - Market Share
4.35% (as of Jul 22)
Gastro-Intestinal - Market Share
0.22% (as of Nov 21)
Gynecology - Market Share
2.63% (as of Nov 21)
Neurological - Market Share
3.84% (as of Nov 21)
Pain - Market Share
3% (as of Dec 22)
Pharmaceutical Sector - Market Share
4.38% (as of Nov 21)
Respiratory - Market Share
1.89% (as of Jul 22)
Sex Stimulants - Market Share
19.22% (as of Nov 21)
Stomatological - Market Share
7.61% (as of Nov 21)
Urology - Market Share
2.08% (as of Jul 22)
Vitamin & Dietary Supplements - Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up -Global Generics

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Therapeutic Area Break-Up -Pharmaceutical Services and Active Ingredients

locked
Source
|
Latest
|
locked
Historic

Therapeutic Area Break-Up

locked
Source
|
Latest
|
locked
Historic

Operating Profit Break-Up

locked
Source
|
Latest
|
locked
Historic

Asset Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    Select a Metric
    • Global DMFs filed (.)
    • Number of ANDA's Filed in USA (.)
    • Number of ANDA's Approved By USFDA (.)
    • Domestic Sales Growth - YoY (%)
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis